Morten S. Hansen

11β-Hydroxysteroid Dehydrogenase Type 1 within Osteoclasts Mediates the Bone Protective Properties of Therapeutic Corticosteroids in Chronic Inflammation

M. Cooper, A. Filer, K. Raza, 2022, International journal of molecular sciences.

Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial

Charlotte Ejersted, Morten S. Hansen, Eva M. Wölfel, 2024, EClinicalMedicine.

Acute Effects of Kisspeptin Administration on Bone Metabolism in Healthy Men

M. Frost, W. Dhillo, E. Mills, 2022, The Journal of clinical endocrinology and metabolism.

Transcriptional reprogramming during human osteoclast differentiation identifies regulators of osteoclast activity

M. Zaiss, Y. Omata, C. Gorvin, 2024, Bone research.

GIP reduces osteoclast activity and improves osteoblast survival in primary human bone cells.

M. Rosenkilde, K. Søe, T. L. Andersen, 2023, European journal of endocrinology.

University of Southern Denmark Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism

M. Kassem, J. Frolich, M. Frost, 2019 .

GIP receptor reduces osteoclast activity and improves osteoblast survival by activating multiple signaling pathways

M. Rosenkilde, K. Søe, T. L. Andersen, 2022, bioRxiv.

Alliances of the gut and bone axis.

M. Frost, Morten S. S. Hansen, Morten S Hansen, 2021, Seminars in cell & developmental biology.

The Antiresorptive Effect of GIP, But Not GLP‐2, Is Preserved in Patients With Hypoparathyroidism—A Randomized Crossover Study

J. Holst, M. Rosenkilde, M. Frost, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Disentangling the relationship between bone turnover and glucose homeostasis: A prospective, population-based twin study

C. Dalgård, K. Kyvik, M. Frost, 2021, Bone reports.